Laboratory of Cell and Tissue Biology, Graduate School of Bioresource Sciences, Nihon University, Fujisawa, Japan.
Genes Cells. 2020 Dec;25(12):811-824. doi: 10.1111/gtc.12814. Epub 2020 Nov 10.
Mature adipocyte-derived dedifferentiated fat (DFAT) cells have been identified to possess similar multipotency to mesenchymal stem cells, but a method for converting DFAT cells into hepatocytes was previously unknown. Here, using comprehensive analysis of gene expression profiles, we have extracted three transcription factors, namely Foxa2, Hnf4a and Sall1 (FHS), that can convert DFAT cells into hepatocytes. Hepatogenic induction has converted FHS-infected DFAT cells into an epithelial-like morphological state and promoted the expression of hepatocyte-specific features. Furthermore, the DFAT-derived hepatocyte-like (D-Hep) cells catalyzed the detoxification of several compounds. These results indicate that the transduction of DFAT cells with three genes, which were extracted by comprehensive gene expression analysis, efficiently generated D-Hep cells with detoxification abilities similar to those of primary hepatocytes. Thus, D-Hep cells may be useful as a new cell source for surrogate hepatocytes and may be applied to drug discovery studies, such as hepatotoxicity screening and drug metabolism tests.
已鉴定出成熟脂肪细胞来源的去分化脂肪(DFAT)细胞具有与间充质干细胞相似的多能性,但此前尚不知道将 DFAT 细胞转化为肝细胞的方法。在这里,我们使用基因表达谱的综合分析,提取了三个转录因子,即 Foxa2、Hnf4a 和 Sall1(FHS),它们可以将 DFAT 细胞转化为肝细胞。肝发生诱导已将 FHS 感染的 DFAT 细胞转化为上皮样形态状态,并促进了肝细胞特异性特征的表达。此外,DFAT 衍生的类肝细胞(D-Hep)细胞催化了几种化合物的解毒。这些结果表明,通过综合基因表达分析提取的三个基因转导 DFAT 细胞,可有效地生成具有与原代肝细胞相似解毒能力的 D-Hep 细胞。因此,D-Hep 细胞可用作替代肝细胞的新细胞来源,并可应用于药物发现研究,例如肝毒性筛选和药物代谢试验。